Experts Urge More Use Of Evista And Other Drugs To Prevent Breast Cancer
Executive Summary
Movement toward a paradigm shift in breast cancer from reactive treatment to prevention could gain support from the long-term results of the Study of Tamoxifen and Raloxifene (STAR) trial